| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | succinyl-CoA:3-oxo-acid CoA-transferase activity | 3.53e-06 | 2 | 38 | 2 | GO:0008260 | |
| GeneOntologyMolecularFunction | CoA-transferase activity | 3.51e-05 | 5 | 38 | 2 | GO:0008410 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 9.80e-05 | 8 | 38 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | glutamate binding | 3.16e-04 | 14 | 38 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 4.71e-04 | 17 | 38 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.48e-04 | 24 | 38 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.20e-03 | 27 | 38 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.58e-03 | 31 | 38 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.84e-03 | 694 | 38 | 6 | GO:0003729 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.13e-03 | 36 | 38 | 2 | GO:0019789 | |
| GeneOntologyBiologicalProcess | ketone body catabolic process | 9.90e-06 | 3 | 38 | 2 | GO:0046952 | |
| MousePheno | abnormal microglial cell chemotaxis | 5.08e-06 | 2 | 32 | 2 | MP:0010761 | |
| MousePheno | Meibomian gland atrophy | 1.06e-04 | 7 | 32 | 2 | MP:0001345 | |
| MousePheno | small Meibomian gland | 1.81e-04 | 9 | 32 | 2 | MP:0013388 | |
| Domain | CoA_transf_AS | 3.82e-06 | 2 | 37 | 2 | IPR004164 | |
| Domain | CoA_trans_fam_I | 3.82e-06 | 2 | 37 | 2 | IPR004165 | |
| Domain | CoA_transf_BS | 3.82e-06 | 2 | 37 | 2 | IPR004163 | |
| Domain | CoA_trans | 3.82e-06 | 2 | 37 | 2 | PF01144 | |
| Domain | 3-oxoacid_CoA-transf_A | 3.82e-06 | 2 | 37 | 2 | IPR012792 | |
| Domain | 3-oxoacid_CoA-transf_B | 3.82e-06 | 2 | 37 | 2 | IPR012791 | |
| Domain | CoA_trans | 3.82e-06 | 2 | 37 | 2 | SM00882 | |
| Domain | 3-oxoacid_CoA-transferase | 3.82e-06 | 2 | 37 | 2 | IPR014388 | |
| Domain | COA_TRANSF_2 | 3.82e-06 | 2 | 37 | 2 | PS01274 | |
| Domain | COA_TRANSF_1 | 3.82e-06 | 2 | 37 | 2 | PS01273 | |
| Domain | Iontro_rcpt | 5.73e-04 | 18 | 37 | 2 | IPR001320 | |
| Domain | Lig_chan | 5.73e-04 | 18 | 37 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 5.73e-04 | 18 | 37 | 2 | PF10613 | |
| Domain | PBPe | 5.73e-04 | 18 | 37 | 2 | SM00079 | |
| Domain | Iono_rcpt_met | 5.73e-04 | 18 | 37 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 5.73e-04 | 18 | 37 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 5.73e-04 | 18 | 37 | 2 | SM00918 | |
| Domain | ANF_receptor | 2.43e-03 | 37 | 37 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 2.43e-03 | 37 | 37 | 2 | IPR001828 | |
| Domain | LAM_G_DOMAIN | 2.57e-03 | 38 | 37 | 2 | PS50025 | |
| Domain | Peripla_BP_I | 2.70e-03 | 39 | 37 | 2 | IPR028082 | |
| Domain | Laminin_G_2 | 2.84e-03 | 40 | 37 | 2 | PF02210 | |
| Domain | LamG | 3.43e-03 | 44 | 37 | 2 | SM00282 | |
| Domain | Laminin_G | 5.89e-03 | 58 | 37 | 2 | IPR001791 | |
| Domain | EGF_3 | 1.12e-02 | 235 | 37 | 3 | PS50026 | |
| Domain | EGF | 1.12e-02 | 235 | 37 | 3 | SM00181 | |
| Domain | EGF-like_dom | 1.30e-02 | 249 | 37 | 3 | IPR000742 | |
| Domain | EGF_1 | 1.39e-02 | 255 | 37 | 3 | PS00022 | |
| Domain | EGF-like_CS | 1.48e-02 | 261 | 37 | 3 | IPR013032 | |
| Domain | - | 1.52e-02 | 95 | 37 | 2 | 2.60.120.200 | |
| Domain | EGF_2 | 1.54e-02 | 265 | 37 | 3 | PS01186 | |
| Pathway | REACTOME_UTILIZATION_OF_KETONE_BODIES | 2.62e-05 | 4 | 30 | 2 | MM15459 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 1.95e-04 | 10 | 30 | 2 | MM15437 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 1.95e-04 | 10 | 30 | 2 | M27706 | |
| Pubmed | 8.10e-07 | 17 | 38 | 3 | 32185508 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12534938 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27225229 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11756565 | ||
| Pubmed | 1.17e-05 | 128 | 38 | 4 | 30995482 | ||
| Pubmed | Neto1 is an auxiliary subunit of native synaptic kainate receptors. | 1.74e-05 | 6 | 38 | 2 | 21734292 | |
| Pubmed | A cellular system that degrades misfolded proteins and protects against neurodegeneration. | 2.43e-05 | 7 | 38 | 2 | 24882209 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 34100982 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 24069373 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 17018287 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 32245946 | ||
| Pubmed | JADE2 Is Essential for Hippocampal Synaptic Plasticity and Cognitive Functions in Mice. | 9.00e-05 | 13 | 38 | 2 | 36008159 | |
| Pubmed | Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function. | 9.00e-05 | 13 | 38 | 2 | 24096375 | |
| Pubmed | Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation. | 9.00e-05 | 13 | 38 | 2 | 21944720 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 31841517 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 36305367 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 19240213 | ||
| Pubmed | 1.29e-04 | 1429 | 38 | 8 | 35140242 | ||
| Pubmed | Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. | 1.56e-04 | 17 | 38 | 2 | 12589020 | |
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 18599437 | ||
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 17589506 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 1.77e-04 | 1496 | 38 | 8 | 32877691 | |
| Pubmed | Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription. | 1.96e-04 | 19 | 38 | 2 | 31442405 | |
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 32579270 | ||
| Pubmed | METTL3-mediated m6A modification is required for cerebellar development. | 2.41e-04 | 21 | 38 | 2 | 29879109 | |
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 8464923 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 30992372 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 3.16e-04 | 24 | 38 | 2 | 35746896 | |
| Pubmed | SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion. | 3.43e-04 | 25 | 38 | 2 | 27480238 | |
| Pubmed | Gamma protocadherins are required for survival of spinal interneurons. | 3.72e-04 | 26 | 38 | 2 | 12467588 | |
| Pubmed | 4.32e-04 | 28 | 38 | 2 | 35942939 | ||
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 4.63e-04 | 29 | 38 | 2 | 19208628 | |
| Pubmed | 5.50e-04 | 347 | 38 | 4 | 16033648 | ||
| Pubmed | 6.38e-04 | 34 | 38 | 2 | 37139431 | ||
| Pubmed | 6.38e-04 | 34 | 38 | 2 | 28069946 | ||
| Pubmed | 6.76e-04 | 35 | 38 | 2 | 22325351 | ||
| Pubmed | 7.56e-04 | 37 | 38 | 2 | 26951610 | ||
| Pubmed | An AUTS2-Polycomb complex activates gene expression in the CNS. | 7.97e-04 | 38 | 38 | 2 | 25519132 | |
| Pubmed | 1.02e-03 | 43 | 38 | 2 | 11827452 | ||
| Pubmed | 1.07e-03 | 44 | 38 | 2 | 23070814 | ||
| CoexpressionAtlas | BM Top 100 - adrenal gland cortex | 5.89e-06 | 70 | 36 | 4 | BM Top 100 - adrenal gland cortex | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.23e-06 | 151 | 38 | 4 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.41e-05 | 173 | 38 | 4 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.51e-05 | 176 | 38 | 4 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 185 | 38 | 4 | fd51fef8c69e34c72017d8371ab0a0d7be5701f2 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 185 | 38 | 4 | bea26e369ae91006052b973cd89b4c49afa9e553 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 192 | 38 | 4 | 7ccdb977320d09f21e70e7718ead73eeb56d0c48 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 192 | 38 | 4 | f206c015f091234e2c86dfa66926e97b2ea99690 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 192 | 38 | 4 | 69963e8dc6d6368243e61da133484eb23225625a | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 192 | 38 | 4 | bfc68af68fdb99ddfe4add49671e4b4c26e6f962 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.48e-05 | 200 | 38 | 4 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.48e-05 | 200 | 38 | 4 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 128 | 38 | 3 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-04 | 147 | 38 | 3 | 48d72b6770cd029dd299676e5d83e6ac62102049 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.92e-04 | 152 | 38 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 153 | 38 | 3 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.04e-04 | 154 | 38 | 3 | c6ecc46b99a783373729f7fae0b23216148ffb78 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-04 | 162 | 38 | 3 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 164 | 38 | 3 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-04 | 164 | 38 | 3 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-04 | 164 | 38 | 3 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.78e-04 | 166 | 38 | 3 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.78e-04 | 166 | 38 | 3 | 021b9344de7957762f81b09a647504b8c8289cf1 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-04 | 167 | 38 | 3 | 9526e2c7673d569d04e0728a2526318e67432e0a | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.85e-04 | 167 | 38 | 3 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.92e-04 | 168 | 38 | 3 | e223bd7ae2a28c007e8b365f30d50d3bee83ba38 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.92e-04 | 168 | 38 | 3 | 237a6a6e3bd3ed0e9f24a964b939bfdad442fc19 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-04 | 169 | 38 | 3 | 6a2ef66d7ff69a92e8c62759482e823a07352440 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.99e-04 | 169 | 38 | 3 | 53e863de064d44e1d36e21fb3dbba37ae020f6e9 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.99e-04 | 169 | 38 | 3 | ec23caecbb0d969307e33e9df8499ddcd1420305 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-04 | 170 | 38 | 3 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-04 | 170 | 38 | 3 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-04 | 170 | 38 | 3 | 3fd37e9b377d6485cea1262c31a8507d18a78514 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.06e-04 | 170 | 38 | 3 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 4.20e-04 | 172 | 38 | 3 | 64928cea7e5b60e4bc4af016454b0173ebcc07c7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-04 | 173 | 38 | 3 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-04 | 173 | 38 | 3 | 0ba64e5385fe714f876002520f8b5202809bf11e | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.34e-04 | 174 | 38 | 3 | 23c7fdfc73170cfc5cdee5bb7fbee0c8bbbbca07 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.34e-04 | 174 | 38 | 3 | 68914ec843f58ecff3e6412544a341daf8a01cac | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-new-cluster|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 174 | 38 | 3 | 718e14d9a4264456459bec4c062c94c3a848d43a | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 175 | 38 | 3 | db6be3e9e339918418fcaf9001ea15207aa6c993 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.41e-04 | 175 | 38 | 3 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.41e-04 | 175 | 38 | 3 | a6d9ca35d3c4b4e3889d0a69b514f63ae630da6b | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 175 | 38 | 3 | 8acac10c9eedccebcf3a3fe31bfee35afa54579f | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 175 | 38 | 3 | 61fdafba120fbda063d4dc05263d6f8d1dcab1e1 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 175 | 38 | 3 | 8de8031fdf2af187642833feb80caa64932897cf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 177 | 38 | 3 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 177 | 38 | 3 | e73e2b6a72630bb56ac2af1cdeedc8f0f828f390 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 177 | 38 | 3 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 38 | 3 | 01c90c3952220cc4d6a7ed9c4d575fe4f2f80fd1 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 38 | 3 | 5ac5257d88fa0dc67714881d6f005f6cea925710 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-04 | 178 | 38 | 3 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 179 | 38 | 3 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-04 | 179 | 38 | 3 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-04 | 179 | 38 | 3 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 179 | 38 | 3 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 180 | 38 | 3 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 181 | 38 | 3 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 181 | 38 | 3 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 4.87e-04 | 181 | 38 | 3 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-04 | 182 | 38 | 3 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-04 | 182 | 38 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-04 | 183 | 38 | 3 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-04 | 183 | 38 | 3 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-04 | 183 | 38 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.03e-04 | 183 | 38 | 3 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.11e-04 | 184 | 38 | 3 | b8ecf58b3bdb25bcba5efc2d764930bb84ab95c8 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.11e-04 | 184 | 38 | 3 | 49705c8fec565b16216bdf48e83e27521f52d99a | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.11e-04 | 184 | 38 | 3 | b232a9cc1d14e1a134b037016d437b93921a4a0f | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 5.19e-04 | 185 | 38 | 3 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.19e-04 | 185 | 38 | 3 | 2adb32096aa3473f8d417e5ce9e65264beca9b52 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 186 | 38 | 3 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | 81d7c3802667190f11e9dcd797ee7b88aadbb8de | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-04 | 187 | 38 | 3 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-04 | 187 | 38 | 3 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-04 | 187 | 38 | 3 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-04 | 187 | 38 | 3 | 208686e6ebc9f3a774bcbe89274457ac9449f90e | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 188 | 38 | 3 | 3dd571bd8e7358b4346dea71f6bf9602dabf583c | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 188 | 38 | 3 | 1b349618f77260564486586b7f5a47a77d12859c | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.44e-04 | 188 | 38 | 3 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 188 | 38 | 3 | b1049003ca79c340bb8c78da66bdc0956e1aebc2 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.44e-04 | 188 | 38 | 3 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 189 | 38 | 3 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | PND10-Epithelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-04 | 189 | 38 | 3 | 89349e226a5512833a94b1bf68056a6985fe4afd | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-04 | 190 | 38 | 3 | 8ff8c586237cf15f930416710bcff45205fe6f70 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-04 | 190 | 38 | 3 | 33d1b0a38267270e87702ba5794f07233acf4955 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 190 | 38 | 3 | a1b5775a21d42633224b7d348f0d12b0589dad12 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-04 | 190 | 38 | 3 | dc20d323cee2741e39fba597263d6418ae0eadaf | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-04 | 190 | 38 | 3 | ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-04 | 190 | 38 | 3 | ee39fb88f31d2d65b5d3e7416db68f5df07f6637 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.69e-04 | 191 | 38 | 3 | f98fc372e579ce69409afbbe0f83c03c7ea62632 | |
| Drug | 2-naphthoic acid | 2.20e-07 | 8 | 37 | 3 | CID000007123 | |
| Drug | AC1L3UHX | 2.57e-06 | 2 | 37 | 2 | CID000095516 | |
| Drug | AC1NQZW7 | 2.57e-06 | 2 | 37 | 2 | CID005282334 | |
| Drug | CPD-627 | 2.57e-06 | 2 | 37 | 2 | CID000439367 | |
| Drug | AC1LCVNZ | 2.57e-06 | 2 | 37 | 2 | CID000656887 | |
| Drug | naphthyl-2-methyl-succinate | 2.57e-06 | 2 | 37 | 2 | CID000656886 | |
| Drug | p-azidobenzoyl-CoA | 7.70e-06 | 3 | 37 | 2 | CID000194163 | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.49e-05 | 194 | 37 | 5 | 3284_UP | |
| Drug | AC1L2LUF | 1.54e-05 | 4 | 37 | 2 | CID000074406 | |
| Drug | 3HB-4HB | 2.56e-05 | 5 | 37 | 2 | CID003081116 | |
| Drug | AC1NS1NJ | 2.56e-05 | 5 | 37 | 2 | CID005327101 | |
| Drug | monoacetoacetin | 2.56e-05 | 5 | 37 | 2 | CID000125624 | |
| Drug | AC1NQZWS | 3.84e-05 | 6 | 37 | 2 | CID005282341 | |
| Drug | 2-bromobutyrate | 3.84e-05 | 6 | 37 | 2 | CID000006655 | |
| Drug | AC1MRLG6 | 3.84e-05 | 6 | 37 | 2 | CID003519889 | |
| Drug | 16 alpha-hydroxydehydroepiandrosterone | 5.37e-05 | 7 | 37 | 2 | CID000102030 | |
| Drug | methyl 3-mercaptopropionate | 5.37e-05 | 7 | 37 | 2 | CID000018050 | |
| Drug | crotonobetainyl-CoA | 5.37e-05 | 7 | 37 | 2 | CID000000591 | |
| Drug | carboxymuconolactone | 5.37e-05 | 7 | 37 | 2 | CID000000543 | |
| Drug | AC1L19VW | 5.37e-05 | 7 | 37 | 2 | CID000000726 | |
| Drug | AC1L1BTU | 5.37e-05 | 7 | 37 | 2 | CID000001603 | |
| Drug | glutaconyl-CoA | 7.15e-05 | 8 | 37 | 2 | CID009543049 | |
| Drug | l-carnityl CoA | 7.15e-05 | 8 | 37 | 2 | CID000000605 | |
| Drug | AC1L9K5A | 7.15e-05 | 8 | 37 | 2 | CID000446832 | |
| Drug | CPD-226 | 9.18e-05 | 9 | 37 | 2 | CID000439705 | |
| Drug | N-phthaloyl-DL-glutamic acid | 1.15e-04 | 10 | 37 | 2 | CID000004804 | |
| Drug | AC1L195D | 1.15e-04 | 10 | 37 | 2 | CID000000399 | |
| Drug | AC1L99L3 | 1.15e-04 | 10 | 37 | 2 | CID000440590 | |
| Drug | rhodoquinone | 1.15e-04 | 10 | 37 | 2 | CID006441300 | |
| Drug | p-hydroxybenzoic acid | 1.40e-04 | 62 | 37 | 3 | CID000000135 | |
| Drug | citramalate | 1.40e-04 | 11 | 37 | 2 | CID000001081 | |
| Drug | AC1L974K | 1.40e-04 | 11 | 37 | 2 | CID000439320 | |
| Drug | AC1L9896 | 1.40e-04 | 11 | 37 | 2 | CID000439892 | |
| Drug | enol-lactone | 1.68e-04 | 12 | 37 | 2 | CID000000104 | |
| Drug | AC1L19KJ | 1.68e-04 | 12 | 37 | 2 | CID000000589 | |
| Drug | AC1L99WA | 1.68e-04 | 12 | 37 | 2 | CID000440753 | |
| Drug | 5-hydroxyvalerate | 1.98e-04 | 13 | 37 | 2 | CID000025945 | |
| Drug | gallant | 1.98e-04 | 13 | 37 | 2 | CID000091743 | |
| Drug | AC1L970B | 2.31e-04 | 14 | 37 | 2 | CID000439266 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.35e-04 | 187 | 37 | 4 | 5420_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.66e-04 | 193 | 37 | 4 | 6846_UP | |
| Drug | 2-methylnaphthalene | 2.66e-04 | 15 | 37 | 2 | CID000007055 | |
| Drug | 3-ketoadipyl-CoA | 2.66e-04 | 15 | 37 | 2 | CID000000094 | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 5740_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; ssMCF7; HG-U133A | 2.76e-04 | 195 | 37 | 4 | 524_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A | 2.82e-04 | 196 | 37 | 4 | 1713_UP | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 4142_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; HL60; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 2518_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 4730_DN | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 4702_UP | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 4422_UP | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 6630_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 4378_DN | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 2.93e-04 | 198 | 37 | 4 | 256_UP | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 1534_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 5078_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; PC3; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 4262_UP | |
| Drug | AC1L9DYZ | 3.04e-04 | 16 | 37 | 2 | CID000443062 | |
| Drug | CoA-oxalate | 3.04e-04 | 16 | 37 | 2 | CID000000973 | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 3.04e-04 | 200 | 37 | 4 | 643_UP | |
| Drug | S-acetyl | 3.87e-04 | 18 | 37 | 2 | CID000137849 | |
| Drug | AC1L193J | 3.87e-04 | 18 | 37 | 2 | CID000000375 | |
| Drug | coproporphyrinogen I | 3.87e-04 | 18 | 37 | 2 | CID000440776 | |
| Drug | carbamylhydrazine | 3.87e-04 | 18 | 37 | 2 | ctd:C010059 | |
| Drug | NSC28026 | 3.87e-04 | 18 | 37 | 2 | CID000000848 | |
| Drug | CTDs | 4.35e-04 | 91 | 37 | 3 | CID003036909 | |
| Disease | cholesteryl ester 24:4 measurement | 2.86e-05 | 7 | 35 | 2 | EFO_0021447 | |
| Disease | cholesteryl ester 24:5 measurement | 8.95e-05 | 12 | 35 | 2 | EFO_0021448 | |
| Disease | response to selective serotonin reuptake inhibitor | 1.27e-04 | 82 | 35 | 3 | EFO_0005658 | |
| Disease | Toxic Epidermal Necrolysis | 5.44e-04 | 29 | 35 | 2 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 5.44e-04 | 29 | 35 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 5.44e-04 | 29 | 35 | 2 | C3658302 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 5.44e-04 | 29 | 35 | 2 | C1274933 | |
| Disease | Stevens-Johnson Syndrome | 5.82e-04 | 30 | 35 | 2 | C0038325 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.78e-04 | 145 | 35 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 7.05e-04 | 33 | 35 | 2 | DOID:4467 (is_marker_for) | |
| Disease | Orofacial cleft | 1.68e-03 | 51 | 35 | 2 | HP_0000202 | |
| Disease | coronary artery calcification | 1.92e-03 | 450 | 35 | 4 | EFO_0004723 | |
| Disease | susceptibility to mononucleosis measurement | 3.05e-03 | 69 | 35 | 2 | EFO_0008403 | |
| Disease | urate measurement | 3.87e-03 | 895 | 35 | 5 | EFO_0004531 | |
| Disease | Alcoholic Intoxication, Chronic | 3.91e-03 | 268 | 35 | 3 | C0001973 | |
| Disease | susceptibility to scarlet fever measurement | 3.98e-03 | 79 | 35 | 2 | EFO_0008409 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 5.46e-03 | 93 | 35 | 2 | DOID:3525 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTYIYGEGGPFLSAS | 186 | P26439 | |
| PGSPILGYTVFYSEV | 61 | Q63HQ2 | |
| SKGYGVGTPIGSPYR | 776 | P39086 | |
| QGPFTYYLLSTGPAT | 3541 | Q6V0I7 | |
| TVFGILLGYPVPYTF | 171 | Q96LT6 | |
| TAFYAGTQPPVIGYL | 451 | P54253 | |
| SFGPYGFSYKVIRVP | 241 | Q9BYV7 | |
| FLYPKTGVTGPYVLG | 66 | P24539 | |
| IPTAGIYGASYVPFA | 531 | A0AV96 | |
| YAVTGFPYPTTGTAV | 206 | A6NFN3 | |
| DIYGYSGVFICGPSP | 936 | Q10570 | |
| YSPAGGATSPGVYQV | 36 | Q7L5A3 | |
| YFPVGPGTGFLYLVN | 61 | Q9BUN8 | |
| IYGKPGGPLFTSAAY | 716 | Q96BY6 | |
| YLTGPGVAGYLTAGT | 2206 | O75165 | |
| TYPYYTPTGEPVFGG | 81 | Q12794 | |
| TYPTCGIGYPVSSAF | 521 | Q6UVJ0 | |
| YTYGPGATTIYPAAG | 346 | P15086 | |
| YTIYIAPGGGAFTTL | 361 | Q06587 | |
| YGTGLGVYLSSAVTP | 251 | O60412 | |
| SGGTTALPLYFVGLY | 261 | Q9H9J2 | |
| GFGPTYVVLAYTLPP | 236 | P35610 | |
| KYIFGLTIPSYTGPG | 221 | Q7LBE3 | |
| PYGSVTFTVYGTPKP | 46 | Q9UN36 | |
| GAPLTVATTGPSVYY | 856 | P0DJD1 | |
| PVPVYAFSIKGPSYG | 451 | P29590 | |
| YPVGGPSQFSTIYSL | 346 | Q9UQ13 | |
| GVPAFYTPTGYGTLV | 151 | P55809 | |
| IPVFGYTSAAAYIPG | 1076 | Q9NZP6 | |
| GVPAFYTPTGYGTLV | 151 | Q9BYC2 | |
| PVVDLAFSGITPYGY | 16 | Q9Y3F4 | |
| VFYIFIPVGSGLGYV | 176 | Q6ZMD2 | |
| GGPSTPGVYTKVSAY | 411 | Q9NRS4 | |
| YGGGSTFPVVHAPYS | 841 | Q8WYQ9 | |
| PGYPALVTYSYGGAV | 781 | Q63HR2 | |
| RVPYGLYQGYGSTVP | 6 | A6NP61 | |
| YTYPPSSLGGTVVDG | 151 | Q9BYJ9 | |
| TFVYVSPGTAYYGIP | 421 | Q6ZT21 | |
| PVSYTAGFYRIPVLG | 106 | Q05586 |